These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 15364922)
1. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia. Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922 [TBL] [Abstract][Full Text] [Related]
3. Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins. Naidu A; Xu Q; Catalano R; Cordell B Brain Res; 2002 Dec; 958(1):100-11. PubMed ID: 12468034 [TBL] [Abstract][Full Text] [Related]
5. Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase. Tringali G; Vairano M; Dello Russo C; Preziosi P; Navarra P Neurosci Lett; 2004 Jan; 354(2):107-10. PubMed ID: 14698450 [TBL] [Abstract][Full Text] [Related]
6. Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts. Madonna R; Di Napoli P; Massaro M; Grilli A; Felaco M; De Caterina A; Tang D; De Caterina R; Geng YJ J Biol Chem; 2005 Apr; 280(14):13503-11. PubMed ID: 15705589 [TBL] [Abstract][Full Text] [Related]
7. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition. Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437 [TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392 [TBL] [Abstract][Full Text] [Related]
10. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins. Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells. Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337 [TBL] [Abstract][Full Text] [Related]
12. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488 [TBL] [Abstract][Full Text] [Related]
13. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529 [TBL] [Abstract][Full Text] [Related]
14. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Mo H; Elson CE Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351 [TBL] [Abstract][Full Text] [Related]
15. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014 [TBL] [Abstract][Full Text] [Related]
16. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease. Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949 [TBL] [Abstract][Full Text] [Related]
17. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498 [TBL] [Abstract][Full Text] [Related]
18. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation. Lee MH; Cho YS; Han YM Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088 [TBL] [Abstract][Full Text] [Related]
19. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. Laufs U; Liao JK J Biol Chem; 1998 Sep; 273(37):24266-71. PubMed ID: 9727051 [TBL] [Abstract][Full Text] [Related]
20. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]